Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumitake Amemiya

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Plos One|September 22, 2011
Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapyMakoto Kadokura, Shinya Maekawa, Ryota Sueki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 3, 2013
Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis CKazuki Komase, Shinya Maekawa, Mika Miura, et al.
Journal of Medical Virology|July 25, 2012
Correlation between pretreatment viral sequences and the emergence of lamivudine resistance in hepatitis B virus infectionRyota Sueki, Shinya Maekawa, Mika Miura, et al.
Hepatology International|October 25, 2011
Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis CMika Miura, Shinya Maekawa, Makoto Kadokura, et al.
The Journal of Infectious Diseases|February 6, 2008
Targeting lipid metabolism in the treatment of hepatitis C virus infectionFumitake Amemiya, Shinya Maekawa, Yoshie Itakura, et al.
Mediators of Inflammation|October 24, 2015
Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular CarcinomaKuniaki Shindo, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology International|October 25, 2011
Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patientsHiroko Shindo, Shinya Maekawa, Kazuki Komase, et al.
Hepatology (Baltimore, Md.)|May 12, 2012
Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infectionShinya Maekawa, Minoru Sakamoto, Mika Miura, et al.
Journal of Virology|March 27, 2015
Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virusMitsuaki Sato, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 9, 2020
Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findingsMasaru Muraoka, Shinya Maekawa, Yuichiro Suzuki, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Plos One|September 22, 2011
Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapyMakoto Kadokura, Shinya Maekawa, Ryota Sueki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 3, 2013
Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis CKazuki Komase, Shinya Maekawa, Mika Miura, et al.
Journal of Medical Virology|July 25, 2012
Correlation between pretreatment viral sequences and the emergence of lamivudine resistance in hepatitis B virus infectionRyota Sueki, Shinya Maekawa, Mika Miura, et al.
Hepatology International|October 25, 2011
Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis CMika Miura, Shinya Maekawa, Makoto Kadokura, et al.
The Journal of Infectious Diseases|February 6, 2008
Targeting lipid metabolism in the treatment of hepatitis C virus infectionFumitake Amemiya, Shinya Maekawa, Yoshie Itakura, et al.
Mediators of Inflammation|October 24, 2015
Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular CarcinomaKuniaki Shindo, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology International|October 25, 2011
Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patientsHiroko Shindo, Shinya Maekawa, Kazuki Komase, et al.
Hepatology (Baltimore, Md.)|May 12, 2012
Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infectionShinya Maekawa, Minoru Sakamoto, Mika Miura, et al.
Journal of Virology|March 27, 2015
Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virusMitsuaki Sato, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 9, 2020
Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findingsMasaru Muraoka, Shinya Maekawa, Yuichiro Suzuki, et al.
Pageof 4